BridgeBio Pharma Income Statement (2018-2026) | BBIO

Income Statement Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue (Quarter)
2.34M10.00M1.69M73.75M0.34M1.87M1.83M1.64M4.09M1.75M211.12M2.17M2.73M5.88M116.63M110.56M120.70M154.18M194.51M243.68M
Cost of Revenue (Quarter)
1.45M1.55M1.35M0.70M0.74M0.65M0.65M0.60M0.60M0.60M0.60M0.60M0.60M2.08M2.64M3.65M6.56M8.11M9.94M15.05M
Gross Profit (Quarter)
0.89M8.45M0.35M73.05M-0.40M1.22M1.18M1.04M3.49M1.15M210.52M1.57M2.13M3.80M113.99M106.91M114.14M146.07M184.58M228.63M
Operating items
Research & Development (Quarter)
104.31M122.20M107.65M108.40M92.51M90.90M92.86M107.49M125.14M130.23M140.97M114.69M120.44M130.35M111.43M111.23M112.87M116.42M126.64M149.45M
Selling, General & Administrative (Quarter)
46.08M54.75M43.71M36.43M31.19M31.86M31.11M36.12M35.78M47.58M65.81M59.52M68.82M94.78M106.36M129.15M137.62M158.09M163.90M186.26M
Restructuring Costs (Quarter)
22.66M8.40M5.02M7.69M3.37M3.53M0.27M0.75M1.16M2.35M4.62M4.69M0.57M0.81M8.84M11.13M
Other Operating Expenses (Quarter)
1.45M1.55M1.35M0.70M0.74M0.65M0.65M0.60M0.60M0.60M2.83M1.14M0.60M2.08M2.64M3.65M6.56M8.11M9.94M15.05M
Operating Expenses (Quarter)
151.84M178.50M175.37M153.92M129.45M131.10M127.99M147.74M161.78M179.16M210.78M177.71M194.48M231.91M221.00M244.84M265.90M293.74M300.47M350.75M
Operating Income (Quarter)
-149.50M-165.61M-173.68M-80.18M-129.12M-129.23M-126.16M-146.10M-157.69M-177.42M0.34M-175.54M-191.75M-226.03M-104.37M-134.28M-145.20M-139.56M-105.96M-107.08M
EBIT (Quarter)
-149.50M-165.61M-173.68M-80.18M-129.12M-129.23M-126.16M-146.10M-157.69M-177.42M0.34M-175.54M-191.75M-226.03M-104.37M-134.28M-145.20M-139.56M-105.96M-107.08M
Non-operating items
Interest & Investment Income (Quarter)
0.23M0.18M-0.25M-0.04M2.42M4.09M0.32M0.07M3.79M5.58M-0.03M-0.01M3.30M4.68M5.38M0.00M6.24M4.33M6.25M6.66M
Other Non Operating Income (Quarter)
-0.68M28.28M-7.58M-10.82M6.33M4.56M-26.59M8.23M21.16M4.25M5.59M
Non Operating Income (Quarter)
-11.52M13.33M-27.65M77.62M-11.08M-11.34M-16.57M-14.60M-21.80M7.09M-36.50M100.00M27.50M-40.21M-65.24M-47.38M-41.28M-55.19M-60.60M-48.81M
Net income details
EBT (Quarter)
-174.56M-180.57M-194.27M-100.50M-146.52M-145.13M-147.91M-166.62M-174.21M-202.30M-35.00M-75.54M-164.25M-266.24M-122.26M-181.66M-186.48M-194.75M-120.03M-155.89M
Tax Provisions (Quarter)
1.15M2.10M-1.54M-0.17M
Profit After Tax (Quarter)
-161.02M-152.28M-201.33M-2.56M-140.19M-140.57M-142.73M-160.70M-179.49M-170.33M-36.16M-75.54M-164.25M-267.39M-169.61M-183.76M-184.94M-194.63M-166.56M-155.89M
Income from Non-Controlling Interests (Quarter)
-5.08M-5.11M-4.93M7.30M-2.85M-2.98M-2.58M-2.80M-2.49M-2.18M-0.94M-2.09M-2.21M-2.34M-2.19M-1.85M-2.19M-1.77M-2.51M-3.67M
Income from Continuing Operations (Quarter)
-174.56M-180.57M-194.27M-100.50M-146.52M-145.13M-147.91M-166.62M-174.21M-202.30M-35.00M-75.54M-164.25M-267.39M-122.26M-183.76M-184.94M-194.59M-120.03M-155.89M
Consolidated Net Income (Quarter)
-174.56M-180.57M-194.27M-100.50M-146.52M-145.13M-147.91M-166.62M-174.21M-202.30M-35.00M-75.54M-164.25M-267.39M-122.26M-183.76M-184.94M-194.59M-120.03M-155.89M
Income towards Parent Company (Quarter)
-174.56M-180.57M-194.27M-100.50M-146.52M-145.13M-147.91M-166.62M-174.21M-202.30M-35.00M-75.54M-164.25M-267.39M-122.26M-183.76M-184.94M-194.59M-120.03M-155.89M
Net Income towards Common Stockholders (Quarter)
-155.94M-147.18M-196.40M-9.86M-137.34M-137.59M-140.16M-157.90M-177.00M-168.15M-35.22M-73.46M-162.04M-265.05M-167.42M-181.90M-182.74M-192.86M-164.04M-152.22M
Additional items
EPS (Basic) (Quarter)
-1.06-1.02-1.35-0.07-0.93-0.93-0.92-0.98-1.08-1.03-0.20-0.39-0.86-1.42-0.88-0.95-0.95-1.01-0.84-0.78
EPS (Diluted) (Quarter)
-1.06-1.02-1.35-0.07-0.93-0.93-0.92-0.98-1.08-1.03-0.20-0.39-0.86-1.42-0.88-0.95-0.95-1.01-0.84-0.78
Shares Outstanding (Quarter)
146.66M144.36M145.88M146.68M147.94M147.47M152.65M160.54M163.31M162.79M178.71M187.59M188.51M186.08M190.15M190.52M191.85M191.53M194.79M195.79M
Shares Outstanding (Diluted) (Quarter)
146.66M144.36M145.88M146.68M147.94M147.47M152.65M160.54M163.31M162.79M178.71M187.59M188.51M186.08M190.15M190.52M191.85M191.53M194.79M195.79M
Shares Outstanding (Entity) (Quarter)
147.09M147.34M147.69M148.24M149.37M150.63M160.44M161.42M174.13M175.08M187.12M188.03M188.99M190.04M189.83M191.16M200.23M202.37M204.39M205.87M
EBITDA (Quarter)
-149.50M-165.61M-173.68M-80.18M-129.12M-129.23M-126.16M-146.10M-157.69M-177.42M0.34M-175.54M-191.75M-226.03M-104.37M-134.28M-145.20M-139.56M-105.96M-107.08M
Interest Expenses (Quarter)
25.30M15.13M20.34M20.28M19.82M19.99M22.06M20.59M20.31M30.46M35.31M66.11M23.06M13.11M23.27M205.28M61.96M9.43M20.32M48.87M
Tax Rate (Quarter)
-0.43%-1.16%0.83%0.08%